Reaction
Meningomyelocele reporting signals
As of the last recalculation, Meningomyelocele appears in 599 FAERS reports alongside 24 co-occurring drug terms. The strongest observed disproportionality signal is ZIDOVUDINE (PRR 182.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Zidovudine | 63 | 182.8 | 183.7 |
| Raltegravir | 42 | 95.0 | 95.2 |
| Nevirapine | 22 | 87.9 | 88.1 |
| Tenofovir Disoproxil Fumarate Tablets | 21 | 87.5 | 87.8 |
| Misoprostol | 23 | 85.3 | 85.5 |
| Lamivudine Oral | 52 | 78.1 | 78.3 |
| Efavirenz | 24 | 77.9 | 78.0 |
| Darunavir | 32 | 77.6 | 77.8 |
| Lamivudine | 59 | 73.5 | 73.6 |
| Abacavir Sulfate | 19 | 70.0 | 70.1 |
| Dolutegravir Sodium | 16 | 63.3 | 63.4 |
| Lopinavir And Ritonavir | 21 | 55.8 | 55.8 |
| Valproate Sodium | 27 | 47.5 | 47.5 |
| Valproic Acid | 39 | 45.9 | 46.0 |
| Ritonavir | 35 | 44.1 | 44.2 |
| Tenofovir Disoproxil Fumarate | 34 | 37.8 | 37.9 |
| Carbamazepine | 50 | 28.2 | 28.2 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 33 | 26.5 | 26.6 |
| Lamotirigine | 45 | 23.5 | 23.5 |
| Lamotrigine Extended-Release | 45 | 23.5 | 23.5 |
| Lamotrigine Chewable Dispersible | 45 | 23.5 | 23.5 |
| Ritonavir 100 Mg | 9 | 21.2 | 21.3 |
| Vigabatrin | 4 | 9.6 | 9.6 |
| Etonogestrel | 6 | 4.4 | 4.4 |